Hospitals in Drug Discount Plan Recoup $9 Billion in HHS Remedy

A $9 billion reimbursement from the Biden administration will serve as the remedy for hospitals shortchanged in a federal drug discount program.

The Health and Human Services Department’s final rule (RIN: 0938-AV18) will reimburse hospitals to offset payment cuts in how they were reimbursed for drugs acquired under the 340B discount drug pricing program.

The remedy comes after the US Supreme Court’s 2022 decision in American Hospital Association v. Becerra,a case in which hospitals said they were shortchanged when the HHS adjusted Medicare payment rates for drugs acquired under the 340B drug discount program from 2018 to ...